The stone-free status depends on the appropriate selection of the urologic treatment according to the stone and excretory tract characteristics, and/or to the patient parameters.
Although the gold standard for the treatment is the stone-free status, the authors believe that the presence of non-infected, nonobstructive, asymptomatic residual fragments, smaller than 4–5 mm, can be treated with an adequate medical therapy in order to prevent stone growth. Further urological treatment is recommended if the clinical indications for stone removal persist.
BalajiK.C., MenonM.Mechanism of stone formation.Urol Clin North Am1997; 24: 1.
2.
ChaussyC., BrendelW., SchmiedtE.Extracorporeally induced destruction of kidney stones by shock waves.Lancet1980; 2: 1265–8.
3.
StreemS.B., YostA., MashaE.Clinical implications of clinically insignicant stone fragments after shock wave lithotripsy.J Urol1996; 155: 1186–90.
4.
DrachG.W., DretlerS., FairW. Report of the United States cooperative study of extracorporeal shock wave lithotripsy.J Urol1986; 135: 1127–33.
5.
YuC.C., LeeY.H., HuangJK. Long-term stone regrowth and recurrence rates after shock wave lithotripsy.Br J Urol1993; 72: 688–91.
6.
NewmanD.M., ScottJ.W., LingemanJ.E.Two-year follow-up of patients treated with extracorporeal shock wave lithotripsy in renal stone treatment.J Endourol1991; 2: 163–71.
7.
ZanettiG., MontanariE., MandressiA. Long-term results of extracorporeal shock wave lithotripsy in renal stone treatment.J Endourol1991; 5: 61–4.
8.
NakamotoT., SagamiK., YamasakiA. Long-term results of endourologic treatment of urinary calculi: investigation of risk factors for recurrence or regrowth.J Endourol1993; 7: 297–301.
9.
ZanettiG., SevesoM., MontanariE. Renal stone fragments following shock wave lithotripsy.J Urol1997; 158: 352–5.
10.
BucholzN.P., Meier-PadalS., RutishauserG.Minor residual fragments after extracorporeal shockwave lithotripsy spontaneous clearance or risk factor for recurrent stone formation?J Endourol1997; 11: 227–32.
11.
WolfJ.S., ClaymanR.V.Percutaneous nephrostolithotomy: What is its role in 1997?Urol Clin North Am1997; 24: 43.
ElbahanasyA.M., ShalhavA.L., HoenigDMLower caliceal stone clearance after shock wave lithotripsy or ureteroscopy: The impact of lower pole radiographic anatomy.J Urol1998; 159: 676–80.
14.
ZhongP., PremingerG.M.Mechanism of differing stone fragility in extracorporeal shockwave lithotripsy.J Endourol1994; 8: 263–8.
15.
DenstedtJ.D., ClaymanR.V., PicusD.D.Comparison of endoscopic and radiological residual fragment rate following percutaneous nephrolithotripsy.J Urol1995; 145: 703–5.
16.
JewettM.A., BombardierC., CaronD. Potential for interobserver and intra.observer variabilità in x-ray review to establish stone-free rates after lithotripsy.J Urol147: 559–62.
17.
GlowackiL.S., BeecroftM.L., CookRJ. The natural history of asyntomatic urolithiasis.J Urol1992; 147: 319–21.
18.
MiddletonW.D., DoddsW.J., LawsonTL. Renal calculi: Senitivity for detection with US.Radiology1988; 167: 239–341.
19.
CoughlinB.F., RisiusB., StreemSB. Abdominal radiograph and renal ultrasound versus excretory urography in the evaluattion of asyntomatic patients after extracorporeal shock wave lithotripsy.J Urol1989; 142: 1419–24.
20.
LehtorantaK., MankinenP., TaariK. Residual stones after percutaneous nephrolithotomy: Sensitivities of different imaging methods in renal stone detection.Ann Chir Gynaecol1995; 84: 43–7.
21.
YostA., MashaE.Clinical implications of clinically insignificant stone fragments after shock wave lithotripsy.J Urol1996; 155: 1186–90.
22.
BrownR.D., AdamsB.V., PakCYC. Reliability of single 24-hour urine testing for the detection of abnormal stone-forming risk factors. In SuttonR.A.L., CameronE.C., WalkerV. (eds): Urolithiasis.New York, Plenum, 1989, pp. 553–6.
23.
BeckE.M., RiehelR.A.Jr.. The fate of residual fragments after extracorporeal lithotripsy monotherapy of infection stones.J Urol1991; 145: 6–10.
24.
NijmanR.J., AckaertK., SholtmeijerRJ. Long-term results of extracorporeal shock wave lithotripsy in children.J Urol1989; 142: 609–11.
25.
FuchsA.M., WolfosonBA, FuchsGJ: Staghorn stone treatment with extracorporeal shock wave lithotripsy monotheraphy: Long-term results.J Endourol1991; 5: 45–9.
26.
CarrL.K.D'A., HoneyJ., JewettM.A.New stone formation: A comparison of extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy.J Urol1996; 155: 1565–7.
27.
MichaelsE.K., FowlerJ.E.Jr.. ESWL monotheraphy for large–volume renal calculi: efficacy and morbidity.Urology1989; 34: 96–9.
28.
MichaelsE.K., FowlerJ.E.Jr., MarianoM.Bacteriuria following extracorporeal shock wave lithotripsy of infection stones.J Urol1988; 140: 254–6.
29.
CicerelloE., MerloF.More on the medical management of residual fragments after SW.Contemporary Urology, February 2000.
30.
PremingerG.M.The metabolic evaluation of patients with recurrent nephrolithiasis. A review of comprensive and simplified approaches.J Urol1989; 141: 760.
31.
CicerelloE., MerloF., MaccatrozzoL., FandellaA., AnselmoG.Metabolic evaluation of infected nephrolithiasis. In KokD.J., RomijnH.C., VerhangenP.C.M., VerkoelenC.F. (eds); Eurolithiasis, Proceedings of the 9th European Symposium on Urolithiasis, Rotterdam, 2001.
32.
EisenbergerF., BubP., SchimdtA.The fate of residual stone fragments after extracorporeal shock wave lithotripsy.J Endourol1992; 6: 217–8.
PearleM., WAtamulL., MullicanM.A.Comparison of non-contrast helical CT and KUB with flexibile nephroscopy for detecting residual stones after percutaneous nephrostolithotomy.J Urol1998; 159: 152A.
35.
FreidR.M., SmithA.D.Chemolysis of urinary calculi. In SmithA.D., BalaniG.H., BogleyDH (eds): Smith's Textbook of Endourology.ST. Louis, Quality Medical Publishing, 1996, pp 274–97.
36.
PremingerG.M., PetersonR., PeterPC. The current role of medical treatment of nephrolithiasis. The impact of improved tecniques of stone removal.J Urol, 1985; 134: 6–10.
37.
PakC.Y., FullerC., SakhaeeK. Long-term treatment of calcium nephrolithiasis with potassium citrateJ Urol1985; 134: 11–9.
38.
PremingerG.M., HarveyJ.A., PakC.Y.C.Comparative of efficacy specific potassium citrate therapy versus conservative management in nephrolithiasis of mild to moderate nephrolithiasis, J Urol1985, 134: 658–61.
39.
PakC.Y.C., FullerC., SakhaeeK. Management of cystine nephrolithiasis with alpha –mercaptopropionilglycine.J Urol1986; 136: 1003–5.
40.
PakC.Y.C., SakheeK., FullerC.Successful management of uric nephrolithiasis with potassium citrate.Kidney Int1986; 30: 422–8.
41.
FineJ.K., PakC.Y.C., PremingerG.M.Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy.J Urol1995; 153: 27–33.
42.
CicerelloE., MerloF., GambaroG., MaccatrozzoL., FandellaA., AnselmoG., BaggioB.Effect of alkaline citrate therapy on clearance of residual renal stone fragments after shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients.J Urol1994; 151: 5–9.
